Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Copyright Confusion Has 'Chilling' Effects in Online Creative Publishing

  • Human mind: Making sense through order

  • Amputee makes history controlling two modular prosthetic limbs

  • Scientists map out how childhood brain tumors relapse

  • Scheduling sleep: Three nighttime habits to improve rest

  • Ability to balance on one leg may reflect brain health, stroke risk

  • Being humble: Research shows E.B. White was right in Charlotte's Web

  • Outreach program gets cessation help to smokers of low socioeconomic status

  • Yoga has potential to reduce risk factors of cardiovascular disease

  • How does prostate cancer form? Parkinson's Link?

  •